 So I'll start with the latter. The R&D costs are definitely high, whether it's Lilly or Norvo Nordisk or whoever is developing these drugs. But ultimately, the price of a drug should align with its value and not the cost to develop or manufacture, for that matter. And these drugs do offer benefits, very important ones. But at their current prices, they're not cost effective. That's the real issue.